BioRegenx (BRGX) Total Assets by Year
BioRegenx Inc closed fiscal year 2025 with $411K in total assets, $4.9M in total liabilities and -$4.5M in shareholder equity. Total assets fell 19.2% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters BioRegenx Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BRGX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BRGX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $337K-30.2% | $411K-19.2% | $1.2M-93.3% | $1.2M-93.6% | $483K-97.4% | $509K-41.3% | $17.4M+50991.4% | $17.9M+20823.5% | $18.6M+23775.1% | $866K+1363.7% | $34K | $86K |
| Total Liabilities | $4.9M+20.5% | $4.9M+27.3% | $4.8M+26.7% | $4.8M+30.9% | $4.0M+14.3% | $3.9M+32.4% | $3.8M+34.2% | $3.7M+37.6% | $3.5M+41.8% | $2.9M+13.5% | $2.8M | $2.7M |
| Total Equity | -$4.5Mn/m | -$4.5Mn/m | -$3.6M-126.9% | -$3.7M-125.7% | -$3.6M-123.6% | -$3.4Mn/m | $13.6Mn/m | $14.2Mn/m | $15.1Mn/m | -$2.1Mn/m | -$2.8Mn/m | -$2.6Mn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More BioRegenx Inc financials
Frequently Asked Questions
BioRegenx Inc closed fiscal year 2025 with $411K in total assets, $4.9M in total liabilities and -$4.5M in shareholder equity.
BioRegenx Inc (BRGX) total assets fell by 19.2% year over year, from $509K to $411K in fiscal year 2025.
Across the 5 fiscal years this page covers, BioRegenx Inc (BRGX) total assets went from $128K in fiscal year 2021 to $411K in fiscal year 2025.
BioRegenx Inc (BRGX) reported $337K in total assets in Q1 2026. This represents a decrease of 30.2% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what BioRegenx Inc (BRGX) reported on that line in every period on record.